Dysregulated expression of PSGL-1 and ADAM8 in Sjögren’s disease: potential contribution to disease pathogenesis
Dysregulated PSGL-1 and ADAM8 expression in SjD circulating cells is associated with important clinical manifestations in SjD patients, supporting their potential relevance as therapeutic targets in this disease and finding two cellular biomarkers that could help improve SjD diagnostic accuracy.